Skip to content
PubMed This is a summary of 70 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 70 referenced papers

Top Authors

Alex G. Ortega‐Loayza
Oregon Health & Science University
Angelo Valerio Marzano
University of Milan
Afsáneh Alavi
Mayo Clinic
Kanade Shinkai
University of California, San Francisco
William W. Huang
Wake Forest University
Stanislav N. Tolkachjov
Baylor University Medical Center
Keiichi Yamanaka
Mie University
Marco Romanelli
University of Pisa
Valentina Dini
University of Pisa
Hywel C Williams
University of Nottingham

Top Institutions

Ranked by publications Top 10 institutions
05

University of California, San Francisco

San Francisco, United States

7 papers
06

Wake Forest University

Winston-Salem, United States

5 papers
07

University of Southern Denmark

Odense, Denmark

3 papers

References

References (70)
  1. 1

    Necrotizing soft tissue infections.

    Sarkar B, Napolitano LM

    Minerva chirurgica 2010; (65(3)):347-62.

    PMID: 20668422
  2. 2

    Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

    Ormerod AD, Thomas KS, Craig FE, et al.

    BMJ (Clinical research ed.) 2015; (350()):h2958 doi:10.1136/bmj.h2958.

    PMID: 26071094
  3. 3

    Pain and pain management in dermatology.

    Beiteke U, Bigge S, Reichenberger C, Gralow I

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2015; (13(10)):967-87 doi:10.1111/ddg.12822.

    PMID: 26408457
  4. 4

    Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.

    Chatzinasiou F, Polymeros D, Panagiotou M, et al.

    Acta dermatovenerologica Croatica : ADC 2016; (24(1)):83-5.

    PMID: 27149138
  5. 5

    Pediatric Pyoderma Gangrenosum: A Retrospective Review of Clinical Features, Etiologic Associations, and Treatment.

    Schoch JJ, Tolkachjov SN, Cappel JA, et al.

    Pediatric dermatology 2017; (34(1)):39-45 doi:10.1111/pde.12990.

    PMID: 27699861
  6. 6

    Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.

    Wu BC, Patel ED, Ortega-Loayza AG

    The British journal of dermatology 2017; (177(1)):72-83 doi:10.1111/bjd.15193.

    PMID: 27864925
  7. 7

    Bullous Pyoderma Gangrenosum With Subungual Involvement Associated With Ulcerative Colitis.

    Aktaş Karabay E, Aksu Cerman A, Kıvanc Altunay İ, Yalçın Ö

    The American Journal of dermatopathology 2017; (39(6)):476-478 doi:10.1097/DAD.0000000000000801.

    PMID: 27893467
  8. 8

    Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).

    Marzano AV, Damiani G, Ceccherini I, et al.

    The British journal of dermatology 2017; (176(6)):1588-1598 doi:10.1111/bjd.15226.

    PMID: 27943240
  9. 9

    Treatment options for pyoderma gangrenosum.

    Quist SR, Kraas L

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2017; (15(1)):34-40 doi:10.1111/ddg.13173.

    PMID: 28140549
  10. 10

    Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis.

    Xia FD, Liu K, Lockwood S, et al.

    Journal of the American Academy of Dermatology 2018; (78(2)):310-314.e1 doi:10.1016/j.jaad.2017.09.040.

    PMID: 28947285
  11. 11

    The safety of treatments used in pyoderma gangrenosum.

    Feldman SR, Lacy FA, Huang WW

    Expert opinion on drug safety 2018; (17(1)):55-61 doi:10.1080/14740338.2018.1396316.

    PMID: 29065721
  12. 12

    Pyoderma Gangrenosum: A Critical Appraisal.

    Shavit E, Alavi A, Sibbald RG

    Advances in skin & wound care 2017; (30(12)):534-542 doi:10.1097/01.ASW.0000526605.34372.9e.

    PMID: 29140836
  13. 13

    Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.

    Afifi L, Sanchez IM, Wallace MM, et al.

    Journal of the American Academy of Dermatology 2018; (78(6)):1195-1204.e1 doi:10.1016/j.jaad.2017.12.049.

    PMID: 29288099
  14. 14

    Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies.

    Wang EA, Steel A, Luxardi G, et al.

    Frontiers in immunology 2017; (8()):1980 doi:10.3389/fimmu.2017.01980.

    PMID: 29379508
  15. 15

    The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum.

    Jockenhöfer F, Wollina U, Salva KA, et al.

    The British journal of dermatology 2019; (180(3)):615-620 doi:10.1111/bjd.16401.

    PMID: 29388188
  16. 16

    Pyoderma gangrenosum: a review of pathogenesis and treatment.

    Ahn C, Negus D, Huang W

    Expert review of clinical immunology 2018; (14(3)):225-233 doi:10.1080/1744666X.2018.1438269.

    PMID: 29406827
  17. 17

    The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.

    Ashchyan HJ, Butler DC, Nelson CA, et al.

    JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.

    PMID: 29450453
  18. 18

    Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

    Maverakis E, Ma C, Shinkai K, et al.

    JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.

    PMID: 29450466
  19. 19

    Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials.

    Partridge ACR, Bai JW, Rosen CF, et al.

    The British journal of dermatology 2018; (179(2)):290-295 doi:10.1111/bjd.16485.

    PMID: 29478243
  20. 20

    Bullous pyoderma gangrenosum as a predictor of hematological malignancies.

    Vacas AS, Bollea-Garlatti ML, Torre AC, Galimberti RL

    Anais brasileiros de dermatologia 2018; (93(1)):133-134 doi:10.1590/abd1806-4841.20187031.

    PMID: 29641716
  21. 21

    Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

    Kridin K, Cohen AD, Amber KT

    American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.

    PMID: 29721816
  22. 22

    Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study.

    Monari P, Moro R, Motolese A, et al.

    International wound journal 2018; (15(6)):875-879 doi:10.1111/iwj.12939.

    PMID: 29877043
  23. 23

    Clinical Features of Neutrophilic Dermatosis Variants Resembling Necrotizing Fasciitis.

    Sanchez IM, Lowenstein S, Johnson KA, et al.

    JAMA dermatology 2019; (155(1)):79-84 doi:10.1001/jamadermatol.2018.3890.

    PMID: 30383110
  24. 24

    Extracutaneous involvement of pyoderma gangrenosum.

    Borda LJ, Wong LL, Marzano AV, Ortega-Loayza AG

    Archives of dermatological research 2019; (311(6)):425-434 doi:10.1007/s00403-019-01912-1.

    PMID: 30923901
  25. 25

    Pyoderma gangrenosum - a guide to diagnosis and management .

    George C, Deroide F, Rustin M

    Clinical medicine (London, England) 2019; (19(3)):224-228 doi:10.7861/clinmedicine.19-3-224.

    PMID: 31092515
  26. 26

    Rare Presentation of Postsurgical Pyoderma Gangrenosum Presenting as Necrotizing Soft Tissue Infection.

    Flynn RL, Chowdhury MH, Rudolph J, Einstein S

    Advances in skin & wound care 2019; (32(11)):507-511 doi:10.1097/01.ASW.0000579692.74662.bb.

    PMID: 31498172
  27. 27

    Pyoderma gangrenosum in hematologic malignancies: A systematic review.

    Montagnon CM, Fracica EA, Patel AA, et al.

    Journal of the American Academy of Dermatology 2020; (82(6)):1346-1359 doi:10.1016/j.jaad.2019.09.032.

    PMID: 31560977
  28. 28

    Case Study on Management of Postsurgical Pyoderma Gangrenosum After Spinal Surgery.

    Ratliff CR

    Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2019; (46(6)):543-546 doi:10.1097/WON.0000000000000587.

    PMID: 31651797
  29. 29

    International Consensus Results: Development of Practice Guidelines for Assessment of Peristomal Body and Stoma Profiles, Patient Engagement, and Patient Follow-up.

    Colwell JC, Bain KA, Hansen AS, et al.

    Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2019; (46(6)):497-504 doi:10.1097/WON.0000000000000599.

    PMID: 31738305
  30. 30

    PG-TIME: A practical approach to the clinical management of pyoderma gangrenosum.

    Janowska A, Oranges T, Fissi A, et al.

    Dermatologic therapy 2020; (33(3)):e13412 doi:10.1111/dth.13412.

    PMID: 32291879
  31. 31

    A Wound Care Specialist's Approach to Pyoderma Gangrenosum.

    Croitoru D, Naderi-Azad S, Sachdeva M, et al.

    Advances in wound care 2020; (9(12)):686-694 doi:10.1089/wound.2020.1168.

    PMID: 32320358
  32. 32

    A case of sporotrichosis infection mimicking pyoderma gangrenosum and the role of tissue culture in diagnosis: A case report.

    Tai F, Jakubovic H, Alabdulrazzaq S, Alavi A

    SAGE open medical case reports 2020; (8()):2050313X20919600 doi:10.1177/2050313X20919600.

    PMID: 32523696
  33. 33

    Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study.

    Yamasaki K, Yamanaka K, Zhao Y, et al.

    The Journal of dermatology 2020; (47(12)):1383-1390 doi:10.1111/1346-8138.15533.

    PMID: 32804433
  34. 34

    A perplexing case of superficial granulomatous pyoderma with sporotrichoid-like distribution.

    Parker J, Liszewski W, Merten AH, et al.

    Dermatology online journal 2020; (26(6)).

    PMID: 32815693
  35. 35

    Pyoderma gangrenosum with thymoma and myasthenia gravis: A case report.

    Tunçez Akyürek F, Akyurek M, Zekey E, et al.

    Journal of cosmetic dermatology 2021; (20(3)):943-946 doi:10.1111/jocd.13717.

    PMID: 32920928
  36. 36

    5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study.

    Janowska A, Papa G, Romanelli M, et al.

    Journal of investigative surgery : the official journal of the Academy of Surgical Research 2022; (35(1)):49-52 doi:10.1080/08941939.2020.1821134.

    PMID: 32969736
  37. 37

    Efficacy and safety of skin grafting in treatment of vasculitic ulcer and pyoderma gangrenosum-A systematic review.

    Morgenstjerne-Schwenck LET, Knudsen JT, Prasad SC

    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2021; (29(2)):240-253 doi:10.1111/wrr.12882.

    PMID: 33377584
  38. 38

    Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.

    Hrin ML, Bashyam AM, Huang WW, Feldman SR

    International journal of dermatology 2021; (60(12)):e486-e492 doi:10.1111/ijd.15539.

    PMID: 33739458
  39. 39

    Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.

    Sawka E, Zhou A, Latour E, et al.

    Clinical rheumatology 2021; (40(10)):3963-3969 doi:10.1007/s10067-021-05768-7.

    PMID: 34002351
  40. 40

    Superficial Granulomatous Pyoderma Successfully Treated with Intravenous Immunoglobulin.

    Borg Grech S, Vella Baldacchino A, Corso R, et al.

    European journal of case reports in internal medicine 2021; (8(9)):002656 doi:10.12890/2021_002656.

    PMID: 34671571
  41. 41

    Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.

    Flora A, Kozera E, Frew JW

    Experimental dermatology 2022; (31(4)):498-515 doi:10.1111/exd.14534.

    PMID: 35114021
  42. 42

    Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection.

    May MR, Rübben A, Lennertz A, et al.

    Journal of personalized medicine 2022; (12(2)) doi:10.3390/jpm12020173.

    PMID: 35207660
  43. 43

    Resource-Limited Management of Presumptive Pyoderma Gangrenosum in an Unsheltered Patient.

    Rasul TF, Mathew M, Anderson JD, et al.

    Cureus 2022; (14(1)):e21629 doi:10.7759/cureus.21629.

    PMID: 35228976
  44. 44

    Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: A single centre, retrospective, observational study over 20 years.

    Kim YJ, Lee KH, Won CH, et al.

    Indian journal of dermatology, venereology and leprology 2023; (89(1)):25-34.

    PMID: 35389018
  45. 45

    Epidermotropism of inflammatory cells differentiates pyoderma gangrenosum from venous leg ulcers.

    Ronicke M, Baur A, Kirr M, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2022; (20(5)):619-627 doi:10.1111/ddg.14708.

    PMID: 35487858
  46. 46

    Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

    Maronese CA, Pimentel MA, Li MM, et al.

    American journal of clinical dermatology 2022; (23(5)):615-634 doi:10.1007/s40257-022-00699-8.

    PMID: 35606650
  47. 47

    Bullous Variant of Pyoderma Gangrenosum in a Patient with Acute Myeloid Leukemia.

    Kwon CI, Lee GW, Kim CY

    Annals of dermatology 2022; (34(3)):212-215 doi:10.5021/ad.2022.34.3.212.

    PMID: 35721340
  48. 48

    Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.

    Nazir A, Zafar A

    Cureus 2022; (14(5)):e25177 doi:10.7759/cureus.25177.

    PMID: 35746991
  49. 49

    Pyoderma Gangrenosum Mimicking Necrotizing Fasciitis on Magnetic Resonance Imaging: A Case Report and Literature Review.

    Park S, Shin H, Lee DH, et al.

    The American journal of case reports 2022; (23()):e931734 doi:10.12659/AJCR.931734.

    PMID: 36045564
  50. 50

    Treatment Strategy for Pyoderma Gangrenosum: Skin Grafting with Immunosuppressive Drugs.

    Nishimura M, Mizutani K, Yokota N, et al.

    Journal of clinical medicine 2022; (11(23)) doi:10.3390/jcm11236924.

    PMID: 36498498
  51. 51

    [Differential diagnoses severe skin infections].

    Hua C, Chosidow O

    La Revue du praticien 2023; (73(2)):153-155.

    PMID: 36916255
  52. 52

    The Clinical Characteristics of Patients With Pyoderma Gangrenosum in a Tertiary Referral Hospital: A Retrospective Cohort Study.

    Afacan Yıldırım E, Can Edek Y, Adısen E

    The international journal of lower extremity wounds 2026; (25(1)):150-154 doi:10.1177/15347346231196957.

    PMID: 37700613
  53. 53

    Necrotizing Sweet Syndrome of the Hand and Forearm in the Immediate Postoperative Period: Case Report.

    Hresko AM, Pickrell BB, Harper CM

    Hand (New York, N.Y.) 2024; (19(7)):NP1-NP7 doi:10.1177/15589447231207978.

    PMID: 37946497
  54. 54

    Wound Debridement in Pyoderma Gangrenosum.

    Taheri A, Mansoori P, Sharif M

    Advances in skin & wound care 2024; (37(2)):107-111 doi:10.1097/ASW.0000000000000092.

    PMID: 38241454
  55. 55

    Pyoderma Gangrenosum: Diagnostic Criteria, Subtypes, Systemic Associations, and Workup.

    Zaino ML, Schadt CR, Callen JP, Owen LG

    Dermatologic clinics 2024; (42(2)):157-170 doi:10.1016/j.det.2023.08.003.

    PMID: 38423678
  56. 56

    Clinical efficacy of crushed prednisolone and hydrocolloid powder in the primary treatment of peristomal pyoderma gangrenosum and correlation to in vitro drug release data.

    Pearson WA, Prentice DA, Lim LY, et al.

    International wound journal 2024; (21(3)):e14808 doi:10.1111/iwj.14808.

    PMID: 38425135
  57. 57

    A Case of Pustular Pyoderma Gangrenosum Misdiagnosed as Acute Febrile Neutrophilic Dermatosis in a Pediatric Patient.

    Yang X, Wu Y, Jiang F, Deng D

    Clinical, cosmetic and investigational dermatology 2024; (17()):493-498 doi:10.2147/CCID.S449404.

    PMID: 38435844
  58. 58

    A Verrucous Plaque Healing with Cribriform Scarring.

    Meena A, Mehta H, Chaterjee D, De D

    Indian dermatology online journal 2024; (15(4)):640-642 doi:10.4103/idoj.idoj_380_23.

    PMID: 39050081
  59. 59

    Assessing the role of wound debridement in pyoderma gangrenosum-A retrospective cohort study.

    Bar D, Beberashvili I

    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2024; (32(6)):941-948 doi:10.1111/wrr.13219.

    PMID: 39262283
  60. 60

    Decoding the Histopathology of Pustular Pyoderma Gangrenosum: A Multidisciplinary Approach to Diagnosis.

    Bavikar R, Singh D

    Cureus 2024; (16(8)):e67059 doi:10.7759/cureus.67059.

    PMID: 39286710
  61. 61

    Topical corticosteroid powder for peristomal pyoderma gangrenosum: a systematic review.

    Kaur M, Kaffenberger BH

    Wounds : a compendium of clinical research and practice 2024; (36(10)):331-337 doi:10.25270/wnds/24020.

    PMID: 39500711
  62. 62

    Pyoderma Gangrenosum in a Patient with Crohn's Disease Treated with Adalimumab: A Case-Based Review and Systematic Review of the Current Literature.

    Fousekis FS, Mpakogiannis K, Karampinis E, et al.

    Clinics and practice 2025; (15(3)) doi:10.3390/clinpract15030057.

    PMID: 40136593
  63. 63

    Laser Therapy in the Treatment of Scarring Secondary to Pyoderma Gangrenosum: A Case Series.

    Vague M, Shea M, Kumar I, et al.

    Lasers in surgery and medicine 2026; (58(5)):373-380 doi:10.1002/lsm.70122.

    PMID: 41845874
  64. 64

    Pyoderma gangrenosum: a case report highlighting the importance of early diagnosis and treatment.

    Hayek SJ, Brodell RT, Doolittle JS, Jackson JD

    International journal of surgery case reports 2026; (138(3)):357-362 doi:10.1097/RC9.0000000000000100.

    PMID: 41847105
  65. 65

    Probable pyoderma gangrenosum complicated with cutaneous Aspergillus flavus infection: case report.

    Sun S, Zhu M, Wen C

    Frontiers in medicine 2026; (13()):1806433 doi:10.3389/fmed.2026.1806433.

    PMID: 42100284
  66. 66

    Clinical Decision-Making and Multidisciplinary Management of Peristomal Pyoderma Gangrenosum in Stage IVB Rectal Cancer: A Case Report-Corticosteroid Response but Fatal Cancer Progression.

    Tanabe H, Ogawa M, Kita M, Kotake T

    Reports (MDPI) 2026; (9(2)) doi:10.3390/reports9020194.

    PMID: 42347107
  67. 67

    Postoperative Pyoderma Gangrenosum Following Varicose Vein Surgery: Recognizing a Rare Surgical Mimic Before Extensive Tissue Loss.

    El Salawi O, Dubois M, De Smet A

    Cureus 2026; (18(7)):e113733 doi:10.7759/cureus.113733.

    PMID: 42544110
  68. 68

    Post-caesarean pyoderma gangrenosum mimicking surgical site infection: a diagnostic pitfall in the postpartum period.

    Tamim Y, Berrada Y, Mejdoubi I, et al.

    Journal of surgical case reports 2026; (2026(8)):rjag696 doi:10.1093/jscr/rjag696.

    PMID: 42592503
  69. 69

    Post-surgical Pyoderma Gangrenosum Following Elective Aesthetic Procedures: A Case Series of 10 Patients and a Multidisciplinary Treatment Approach.

    Birck MS, Padilha DZ, Borges VPB, et al.

    Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 2026; (59(3)):218-223 doi:10.1055/s-0045-1814165.

    PMID: 42592637
  70. 70

    The use of over-the-counter aerosolized triamcinolone acetonide in the treatment of peristomal pyoderma gangrenosum: a case series.

    Hill JZ, Chirumamilla V, Kaffenberger BH

    Wounds : a compendium of clinical research and practice 2026; (38(6)):137-140 doi:10.25270/wnds/25128.

    PMID: 42640996